Key points are not available for this paper at this time.
Improved clinical care and effective immunosuppressive strategies have prolonged the life of renal allografts, though not indefinitely. Increasing number of patients are coming up for re-transplantation. We report our experience with renal retransplants at our centre
RAVI et al. (Mon,) studied this question.